Compare Binh Dinh Pharmaceutical & Medical Equipment JSC with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
VND 4,913,442 Million (Small Cap)
16.00
NA
3.05%
-0.27
17.08%
2.87
Revenue and Profits:
Net Sales:
509,952 Million
(Quarterly Results - Dec 2025)
Net Profit:
59,493 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.9%
0%
-4.9%
6 Months
-9.18%
0%
-9.18%
1 Year
27.34%
0%
27.34%
2 Years
41.23%
0%
41.23%
3 Years
45.61%
0%
45.61%
4 Years
111.85%
0%
111.85%
5 Years
102.58%
0%
102.58%
Binh Dinh Pharmaceutical & Medical Equipment JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.75%
EBIT Growth (5y)
12.83%
EBIT to Interest (avg)
70.23
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
1.07
Tax Ratio
15.36%
Dividend Payout Ratio
79.06%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
22.57%
ROE (avg)
17.11%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.07
EV to EBIT
13.70
EV to EBITDA
11.92
EV to Capital Employed
3.84
EV to Sales
2.50
PEG Ratio
NA
Dividend Yield
2.98%
ROCE (Latest)
28.06%
ROE (Latest)
18.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
509,951.70
439,698.40
15.98%
Operating Profit (PBDIT) excl Other Income
71,108.10
88,463.30
-19.62%
Interest
1,002.00
1,340.00
-25.22%
Exceptional Items
0.00
0.00
Consolidate Net Profit
59,493.10
59,909.00
-0.69%
Operating Profit Margin (Excl OI)
114.60%
172.00%
-5.74%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 15.98% vs -7.34% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -0.69% vs -33.68% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,865,232.20
1,727,548.40
7.97%
Operating Profit (PBDIT) excl Other Income
375,720.90
353,704.60
6.22%
Interest
3,846.60
4,058.10
-5.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
290,747.90
236,656.50
22.86%
Operating Profit Margin (Excl OI)
174.10%
176.90%
-0.28%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 7.97% vs 4.59% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 22.86% vs 2.28% in Dec 2024
About Binh Dinh Pharmaceutical & Medical Equipment JSC 
Binh Dinh Pharmaceutical & Medical Equipment JSC
Pharmaceuticals & Biotechnology
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) is a Vietnam-based company primarily engaged in pharmaceuticals sector. The Company's leading business activities are the production and wholesale of medicines, including antibiotics, antipyretics, pain relievers, cardiovascular drugs, antifungal and antiviral drugs, respiratory drugs, vitamins and functional food, among others. Bidiphar is also involved in the manufacture and distribution of medical equipment, supplies and packaging.
Company Coordinates 
Company Details
498 Nguyen Thai Hoc, Phuong Quang Trung , QUI NHON None : None
Registrar Details






